LNSR Strangle Strategy
LNSR (LENSAR, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
LNSR (LENSAR, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $69.8M, a trailing P/E of 2.39, a beta of 0.84 versus the broader market, a 52-week range of 5.06-14.31, average daily share volume of 122K, a public-listing history dating back to 2020, approximately 140 full-time employees. These structural characteristics shape how LNSR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.84 places LNSR roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. The trailing P/E of 2.39 is on the value side, where IV often compresses outside event windows because forward growth expectations are already discounted into the share price.
What is a strangle on LNSR?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current LNSR snapshot
As of May 14, 2026, spot at $5.82, ATM IV 55.30%, IV rank 7.49%, expected move 15.85%. The strangle on LNSR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this strangle structure on LNSR specifically: LNSR IV at 55.30% is on the cheap side of its 1-year range, which favors premium-buying structures like a LNSR strangle, with a market-implied 1-standard-deviation move of approximately 15.85% (roughly $0.92 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated LNSR expiries trade a higher absolute premium for lower per-day decay. Position sizing on LNSR should anchor to the underlying notional of $5.82 per share and to the trader's directional view on LNSR stock.
LNSR strangle setup
The LNSR strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With LNSR near $5.82, the first option leg uses a $6.11 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed LNSR chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 LNSR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $6.11 | N/A |
| Buy 1 | Put | $5.53 | N/A |
LNSR strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
LNSR strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on LNSR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on LNSR
Strangles on LNSR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the LNSR chain.
LNSR thesis for this strangle
The market-implied 1-standard-deviation range for LNSR extends from approximately $4.90 on the downside to $6.74 on the upside. A LNSR long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current LNSR IV rank near 7.49% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on LNSR at 55.30%. As a Healthcare name, LNSR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to LNSR-specific events.
LNSR strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. LNSR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move LNSR alongside the broader basket even when LNSR-specific fundamentals are unchanged. Always rebuild the position from current LNSR chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on LNSR?
- A strangle on LNSR is the strangle strategy applied to LNSR (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With LNSR stock trading near $5.82, the strikes shown on this page are snapped to the nearest listed LNSR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are LNSR strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the LNSR strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 55.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a LNSR strangle?
- The breakeven for the LNSR strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current LNSR market-implied 1-standard-deviation expected move is approximately 15.85%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on LNSR?
- Strangles on LNSR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the LNSR chain.
- How does current LNSR implied volatility affect this strangle?
- LNSR ATM IV is at 55.30% with IV rank near 7.49%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.